Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anastrozole-induced hepatotoxicity.

Eva Zapata1, Leire Zubiaurre, Luis Bujanda

  • 1Gastroenterology and Hepatology Units, Mendaro Hospital, Mendaro, Gipúzkoa, Spain. ezapata@hmen.oskidetza.net

European Journal of Gastroenterology & Hepatology
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Colorectal Cancer Incidence After Adenoma and Serrated Polyp Removal: Results From the Colonprev Trial.

United European gastroenterology journal·2026
Same author

Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.

Alimentary pharmacology & therapeutics·2026
Same author

Colonoscopy versus biennial FIT screening: a post hoc sustained-strategy analysis of the COLONPREV Trial.

Gut·2026
Same author

Th1/Th17 cytokine signatures correlate with Crohn's disease activity in a 54‑week cohort of patients treated with adalimumab.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Calling for Diversity: Improving Transfusion Safety Through High-Throughput Blood Group Microarray Genotyping.

Genomics, proteomics & bioinformatics·2026
Same author

MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.

Signal transduction and targeted therapy·2026
Same journal

Comment on 'Associations between 12 insulin resistance surrogates with metabolic dysfunction-associated steatotic liver disease risk and all-cause mortality: data from the National Health and Nutrition Examination Survey III (1988-1994)'.

European journal of gastroenterology & hepatology·2026
Same journal

Alarm symptoms at diagnosis of coeliac disease and long-term outcomes.

European journal of gastroenterology & hepatology·2026
Same journal

Artificial intelligence-integrated nanotherapeutics for rare Peutz-Jeghers syndrome hamartoma-induced obstructions: latest clearance strategies.

European journal of gastroenterology & hepatology·2026
Same journal

'Presence of alarm symptoms at coeliac disease diagnosis is not associated with poorer long-term treatment outcomes' [Letter].

European journal of gastroenterology & hepatology·2026
Same journal

Atrial fibrillation in patients with alcohol-associated hepatitis leads to increased mortality.

European journal of gastroenterology & hepatology·2026
Same journal

Association between albumin-bilirubin score, model for end-stage liver disease score, platelet-albumin-bilirubin score, and acute-on-chronic liver failure complications: a cross-sectional study in a Chinese population.

European journal of gastroenterology & hepatology·2026
See all related articles

A rare case of liver damage (hepatotoxicity) occurred in an elderly woman taking anastrazole, a hormonal antineoplastic drug. This is the first documented instance of such a reaction to this medication.

Area of Science:

  • Endocrinology
  • Oncology
  • Hepatology

Background:

  • Hormonal antineoplastic drugs, such as anastrazole, are widely used in cancer therapy.
  • Aromatase inhibitors are crucial in managing hormone-sensitive cancers, particularly in postmenopausal women.

Observation:

  • An elderly female patient developed significant liver injury.
  • The patient was undergoing treatment with anastrazole for a hormonal antineoplastic indication.

Findings:

  • Hepatotoxicity was directly linked to anastrazole administration.
  • This represents the first reported case of anastrazole-induced liver injury in medical literature.

Implications:

  • Clinicians should be vigilant for potential hepatotoxicity in patients receiving anastrazole.

Related Experiment Videos

  • Further research may be warranted to elucidate the mechanism of anastrazole-induced liver injury.
  • This case highlights the importance of monitoring liver function in patients on hormonal antineoplastic therapy.